The Association of Variants within Types V and XI Collagen Genes with Knee Joint Laxity Measurements

Joint laxity is a multifactorial phenotype with a heritable component. Mutations or common polymorphisms within the α1(V) (COL5A1), α1(XI) (COL11A1) and α2(XI) (COL11A2) collagen genes have been reported or proposed to associate with joint hypermobility, range of motion and/or genu recurvatum. The aim of this study was to investigate whether polymorphisms within these collagen-encoding genes are associated with measurements of knee joint laxity and computed ligament length changes within the non-dominant leg. One hundred and six healthy participants were assessed for genu recurvatum (knee hyperextension), anterior-posterior tibial translation, external-internal tibial rotation and ligament length changes during knee rotation of their non-dominant leg. Participants were genotyped for COL5A1 rs12722 (T/C), COL11A1 rs3753841 (C/T), COL11A1 rs1676486 (T/C) and COL11A2 rs1799907 (A/T). The genotype-genotype combination of any two or more of the four COL5A1 rs12722 CC, COL11A1 rs3753841 CC, COL11A1 rs1676486 TT and COL11A2 rs1799907 AA genotypes was associated with decreased active and passive knee hyperextension. These genotype-genotype combinations, including sex (male), increased age and decreased body mass collectively, also contributed to decreased passive knee hyperextension. These findings suggest that COL5A1, COL11A1 and COL11A2 gene-gene interactions are associated with knee hyperextension measurements of the non-dominant leg of healthy individuals.


Introduction
Joint laxity, which is a multifactorial trait with a heritable component, is defined as the measured movement constrained by the structure of its ligaments, shape of bones and joint congruency [1,2]. Symptomatic joint hypermobility is a common clinical feature of classic Ehlers-Danlos syndrome (EDS), which is often caused by mutations within the α1(V) collagen gene (COL5A1) [3]. Furthermore, it was previously proposed that COL5A1, which encodes the α(1) chain of type V collagen, is associated with hypermobility spectrum disorders [4] and, although joint hypermobility is not a clinical feature, multifocal fibromuscular dysplasia (FMDMF) [5]. Common genetic variants within the COL5A1 gene are also associated with several musculoskeletal soft tissue injuries [6], including anterior cruciate ligament (ACL) ruptures and other ligament injuries [7]. Interestingly, increased One-hundred and six moderately active (at least 150 min of moderate intensity exercise per week), apparently healthy participants were recruited from nearby fitness centres within the greater Cape Town area, as well as through social media and word of mouth, between February 2016 and October 2018. Participants were required to have no history of spinal cord injury or any history of injury to the non-dominant lower limb. An additional 28 participants with a history of injury (14 knee and 4 ankle) or treatment (n = 9) to the non-dominant lower limb were also recruited and included with the 106 participants in a sub-analysis (n = 134). Prior to testing, all participants were required to sign an informed consent form. Questionnaires detailing personal particulars, sporting activities, as well as previous medical and injury history, were completed by all participants. Since this was a genetic study, all participants included in the study were of self-reported European ancestry to minimise the possible effect of population stratification. Leg dominance was also self-reported and for the purpose of this study, data from the non-dominant leg was reported. This study Sit and reach assessments were measured as previously described [10]. Since this study was investigating inherent genotype effects, participants were instructed to refrain from performing any warm-up exercises prior to testing. This modification was adopted due to unpublished observations that range of motion (ROM) responds to external stimuli such as a warm-up in an individualised manner (Miller C-J et al., personal communication). The test was repeated and the larger of the two measurements was recorded. The Beighton Score was used to assess GJH as previously described [2].

Knee Joint Laxity Assessments
Passive and active genu recurvatum were measured in degrees as previously described using a goniometer while the participants were in the supine position on a plinth with a bolster under both feet. Lower degree values indicated increased knee hyperextension. For the active measurement, participants were instructed to hyperextend their leg [21].
The KT-1000 (MEDmetric Corporation, San Diego, CA, USA) arthrometer was used to assess anterior and posterior tibial translation, relative to the femur, at 133 N while the knee was positioned at 30 • flexion. Active displacement was measured while the participant raised their foot in a controlled manner. Maximum displacement was recorded after the tibia was manually displaced by the tester until the endpoint.
Tibial external-internal rotation was measured using the Robotic Knee Testing (RKT) device as previously described [22]. The resulting data were used to produce load deformation curves, where the curve was divided into three sections: external rotation, area of play and internal rotation, which were defined by the turning points of the curve. External and internal rotation refers to the amount of rotation which occurred between the respective outermost point of the curve and turning points. Slack describes the amount of rotation which occurred between the two turning points of the curve (in the area of play) [22]. Reliability of the genu recurvatum and the anterior-posterior knee laxity measurements are summarised (Supplementary Tables S1 and S2) and the reliability of the RKT measurements has previously been published [22].

Measuring Ligament Length Change
Absolute knee-stabilising ligament length changes were calculated from the RKT motion data. A previously validated musculoskeletal knee model with six degrees of freedom was used for this study [23]. The model was obtained from https://simtk.org/frs/?group_ id=933 (accessed on 1 October 2019) and was visualised using OpenSim software (version 3.3) (Stanford University, Stanford, CA, USA). Flexion/extension, abduction/adduction, internal/external rotation and medial/lateral translation kinematic data obtained from the RKT testing were used in the model. Ligament length changes were determined from maximum external and internal rotation in four ligaments within the knee joint, separated into ten bundles. This included two anterior cruciate ligament bundles (aACL and pACL), two posterior cruciate ligament bundles (aPCL and pPCL), three medial collateral ligament bundles (aMCL, iMCL and pMCL), two deep layer bundles of MCL (aDMCL and pDMCL) and one lateral collateral ligament bundle (LCL). Absolute ligament length change was the difference between initial (at maximum external rotation) and final (maximum internal rotation) lengths of a ligament.

DNA Extraction and Genotyping
A 5 mL venous blood sample was collected from the forearm of participants and stored at −20 • C until DNA extraction. DNA was extracted as previously described and the DNA samples were stored at −20 • C [24]. DNA samples were genotyped for COL5A1 rs12722 (C/T) using PCR and restriction fragment length polymorphism analysis as previously described [24]. The rs12722 T allele and TT genotype frequencies within the European population are 44.5 and 21.0%, respectively (www.ensemble.org; accessed on 4 November 2022).
TaqMan™ Genotyping Assays (Applied Biosystems, Waltham, MA, USA) were used for genotyping the DNA samples for COL11A1 rs1676486 (T/C) and rs3753841 (C/T), as well as COL11A2 rs1799907 (A/T), using the QuantStudio ® 3 Real-Time PCR System (Applied Biosystems) and Genotyping Application on the Thermo Fisher Cloud (https: //apps.thermofisher.com/apps/spa/, (accessed on 4 November 2022)). All plates included negative controls containing no DNA as well as additional positive controls with known genotypes. All laboratory work was conducted at the Health through Physical Activity, Lifestyle and Sport Research Centre (HPALS) laboratories, Sports Science Institute of South Africa Building, Newlands, Cape Town. In the European population, the minor allele and genotype frequencies of rs3753841 is 38.8% C and 14.3% CC; rs1676486 is 17.0% T and 2.8% TT; and rs1799907 is 27.7% T and TT 8.9% (www.ensemble.org; accessed on 4 November 2022).
The TT and CT genotypes of COL5A1 rs12722 were combined for all analyses because of the previous association of the injury protective CC genotype with ROM measurements [10,25]. The genotype profile combinations used in all analyses for rs3753841 (T/C), rs1676486 (C/T) and rs1799907 (T/A) were based on the previous association of the rs3753841 T, rs1676486 C and rs1799907 T allele-allele interactions with increased risk of Achilles tendinopathy [16] and the independent association of the rs3753841 TT genotype and the rs3753841 T and rs1676486 C allele-allele interactions with increased risk of carpal tunnel syndrome [17]. Similar to the COL5A1 analysis, the COL11A1 and COL11A2 genotypes containing the allele associated with increased risk of musculoskeletal soft tissue injury were combined and compared to the protective CC, TT and AA genotypes for rs3753841, rs1676486 and rs1799907, respectively.

Statistical Analysis
The required sample size for this study was based on previously published research reporting the collagen genotype effects on knee joint laxity measurements [11]. The Shapiro-Wilk test was used to test for normality. Categorical data were compared using the Chisquared or Fisher's Exact tests. Unpaired t-test or one-way ANOVA were used for continuous normally distributed data, while Mann Whitney-U or Kruskal-Wallis tests were used for non-parametric data. Test for linear trend or Dunn's multiple comparisons tests were used to compare groups.
Hardy-Weinberg Equilibrium was also calculated using R statistical software. The IBM SPSS Statistics software (version 25) or Prism (version 9.4.1) were used for all remaining statistical analyses. Significance was set at p < 0.05. Data were presented as mean and standard deviation if normally distributed, or as median and interquartile ranges (IQR) if not normally distributed.
Genotype scores were calculated as a proxy for genotype-genotype interactions and were based on the previous independent and/or collective association of COL5A1 (rs12722), COL11A1 (rs3753841 and rs1676486) and COL11A2 (rs1799907) with musculoskeletal soft tissue injuries [16,17,26]. Each of the reduced injury risk COL5A1 rs12722 CC, COL11A1 rs3753841 CC, COL11A1 rs1676486 TT and COL11A2 rs1799907 AA genotypes were given a score of 2, such that participants with none, one, two, three or all four of the associated reduced injury risk genotypes had a total score of 0, 2, 4 or 8, respectively (none of the participants had a genotype score of 8).
To explore which physical characteristics or genotypes were significant predictors of knee joint laxity measurements, multiple linear regression analyses using backward elimination were performed. Assumptions of linear regression were tested.
There were no genotype effects for COL5A1 rs12722, COL11A1 rs3753841, COL11A1 rs1676486 or COL11A2 rs1799907 on the general characteristics of the participants, their flexibility training, Beighton scores or sit and reach measurements (Supplementary Tables S3 and S4). Similarly, there were no genotype effects for COL5A1 rs12722, COL11A1 rs3753841 or COL11A2 rs1799907 on any of the general characteristics when the subset of participants tested using the RKT device were analysed. COL11A1 rs1676486 could not be included in the sub-analysis because only three participants had the protective TT genotype (Supplementary Tables S5 and S6).

Association of Collagen Genotypes with Knee Laxity Measurements
There was a significant (p = 0.017) decrease in the average external rotation measurement of the COL5A1 rs12722 CC genotype group (4.6 ± 1.5 • ) compared to the combined TT and CT genotype group (5.6 ± 1.1 • ) (Supplementary Table S7). There were no other significant differences between the genu recurvatum, anterior-posterior tibial translation or external-internal tibial rotation measurements and the COL5A1 (rs12722), COL11A1 (rs3753841, rs1676486) or COL11A2 (rs1799907) genotype groups in the non-dominant leg (Supplementary Tables S7 and S8). Similar results were obtained when the 28 additional participants with a history of non-dominant lower limb injury and/or treatment were included in the analysis (Supplementary Tables S9-S12).
In order to investigate type V and XI collagen genotype interactions, genotype scores were calculated so that participants with none, any one, any two, any three or all four of the COL5A1 rs12722 CC, COL11A1 rs3753841 CC and/or rs1676486 TT and/or COL11A2 rs1799907 AA genotypes had genotype scores of 0, 2, 4, 6 and 8, respectively. None of the participants had all four genotypes (genotype score of 8). Genotype scores of 4 (n = 13) and 6 (n = 4) were combined for the analysis. There were no genotype score effects on the general characteristics of the participants, their flexibility training, Beighton scores or sit and reach measurements when all the participants or only the subset of participants tested using the RKT device were analysed (Supplementary Tables S13 and S14).
The average active genu recurvatum of the participants with a genotype score of 0 was lower (greater knee hyperextension) than that of participants with a genotype score of 4 or 6 (score 0: 173.4 ± 5.3 • , n = 41; score 2 175.3 ± 6.1 • , n = 44; score 4 or 6 176.7 ± 5.4 • , n = 17; p for linear trend 0.029) ( Figure 1A). Similarly, the median passive genu recurvatum of the 0 genotype score group was significantly lower (p = 0.048) that that of the 4 or  Table S15). In support of this finding, there was a significant positive correlation between increase in genotype score and an increase in active (r = 0.245, p = 0.013) and passive (r = 0.217, p = 0.029) genu recurvatum of the non-dominant knee, but none of the other measurements. Similar results were obtained when the 28 additional participants with a history of non-dominant lower limb injury and/or treatment were included in the analysis (Supplementary Tables S16 and S17). Interestingly, 17.3% (n = 9), 10.3% (n = 6) and 5.0% (n = 1) of the participants with genotype scores of 0, 2 and 4/6, respectively, were able to extend their non-dominant knee beyond 10 • (hyperextension) during the Beighton test.
increase in active (r = 0.245, p = 0.013) and passive (r = 0.217, p = 0.029) genu recurvatum of the non-dominant knee, but none of the other measurements. Similar results were obtained when the 28 additional participants with a history of non-dominant lower limb injury and/or treatment were included in the analysis (Supplementary Tables S16 and S17). Interestingly, 17.3% (n = 9), 10.3% (n = 6) and 5.0% (n = 1) of the participants with genotype scores of 0, 2 and 4/6, respectively, were able to extend their non-dominant knee beyond 10° (hyperextension) during the Beighton test.

Contribution of Collagen Genotype Score to the Multiple Linear Regression Models
The COL5A1, COL11A1 and COL11A2 genotype score, as well as age, sex and body mass were significant predictors of measurements of passive genu recurvatum, and the model explained 18% of the variance compared to 15% when genotype was not included

Contribution of Collagen Genotype Score to the Multiple Linear Regression Models
The COL5A1, COL11A1 and COL11A2 genotype score, as well as age, sex and body mass were significant predictors of measurements of passive genu recurvatum, and the model explained 18% of the variance compared to 15% when genotype was not included in the model (Table 1). Specifically, the analysis showed that being a male, having a one unit increase in age (year), a one kg decrease in body mass and a genotype score of 4 or 6 was predicted to decrease passive knee hyperextension by 5.00 • , 0.23 • , 0.13 • and 3.55 • , respectively, when all of the other variables were held constant. The genotype score was however not considered to be a significant predictor of active genu recurvatum (Supplementary Table S18). Similar results were obtained when the 28 additional participants with a history of non-dominant lower limb injury and/or treatment were included in the analysis (Supplementary Table S19). , α1(XI) (COL11A1) and α2(XI) (COL11A2) collagen genotyping score coding: 0, 2 and 4 or 6. Participants received a genotype score of 2 for the COL5A1 rs12722 CC, COL11A1 rs3753841 CC, COL11A1 rs1676486 TT and/or COL11A1 rs1799907 AA genotypes and 0 for all other genotypes. Genotype scores, therefore, ranged from 0 (none of the injury protective genotypes) to 8 (all four injury protective genotypes). None of the participants had a genotype score of 8. An increase in the measurement of genu recurvatum in degrees indicates decrease in the amount of hyperextension.

Ligament Length Change
There were no significant differences in knee ligament length changes between the COL5A1, COL11A1 and COL11A2 genotype score groups (Supplementary Table S20).

Discussion
The main novel finding of this study was that participants with any two or more of the COL5A1 rs12722 CC, COL11A1 rs3753841 CC, COL11A1 rs1676486 TT and COL11A2 rs1799907 AA genotypes were significantly associated with reduced passive and active knee hyperextension of the non-dominant leg. Furthermore, these genotype combinations were also found to predict measurements of only passive knee hyperextension in a multiple linear regression model, where the effect size of the overall model was considered to be medium [27]. Additionally, the external tibial rotation was significantly lower in the COL5A1 rs12722 CC genotype group. No other genetic associations were noted with any of the anterior-posterior tibial translation nor external-internal tibial rotation measurements.
The CC genotype of rs12722, which is located within the functional COL5A1 3 -UTR and is associated with increased mRNA degradation [28], was previously reported to be independently associated with increased sit and reach measurements in older, healthy participants of self-reported European ancestry [10], as well as with increased straight leg raise (SLR) measurements in young Asian college students [25]. This variant was however not associated with SLR measurements in Korean ballerinas [29] and Japanese athletes [30], as well as with whole body laxity [25]. Similar to previous studies, COL5A1 rs12722 was not independently associated with sit and reach measurements in the younger participants included in this study [10,29,30]. The COL5A1 rs12722 CC genotype was associated with increased extensible tendon structures for knee extensors, but not for plantar flexors [31], while the T allele was associated with greater measures of mechanical stiffness of the quadriceps muscle-tendon at moderate contraction levels [32]. It was however not associated with the volume, elastic modulus and Z of the patellar tendon [33]. Although not all studies have reported an association, several have reported an independent association of the COL5A1 rs12722 CC genotype and/or C allele with a reduced risk (protective effect) of musculoskeletal soft tissue injuries, predominately tendinopathy (reviewed in [26]).
Types V and XI collagen are both fibril-forming collagens that are required to work in a coordinated manner to regulate nucleation and assembly of the collagen fibril within the developing tendon and other tissues [12]. Both COL11A1 rs3753841 and rs1676486 are non-synonymous, resulting in substitutions of a leucine with a proline and a proline with a serine, respectively [34]. The rs1676486 T allele has also been reported to be associated with increased mRNA degradation [35]. The COL11A2 rs1799907 variant produces different isoforms of the α2(XI) chain within the terminal acidic domain, an important binding site for a number of other molecules. It has been suggested that this alteration may affect the deposition of other collagen molecules on the fibril [36]. Since several variants have been shown to regulate mRNA degradation of type V and XI collagen mRNA, Hay et al. (2013) have proposed that these variants result in altered levels of types V and XI collagen production [16].
Compared to COL5A1, the potential biological effects of the COL11A1 and COL11A2 variants investigated in this study on musculoskeletal tissue function and properties have, to our knowledge, not been investigated. The COL11A1 rs3753841 and/or COL11A2 rs1799907 variants have however been associated with lumbar disc herniation [37], limbus vertebra in gymnasts [38], lumbar spine stenosis [39], ossification of the posterior longitudinal ligament of the spine [36] and rheumatoid arthritis [40]. In addition, interactions between the COL11A1 rs3753841 T, COL11A1 rs1676486 C, COL11A2 rs1799907 T and/or COL5A1 rs7174644 AGGG alleles, the latter of which is also located within the functional COL5A1 3 -UTR, were previously reported to be associated with increased risk of Achilles tendinopathy in two populations [16] and carpal tunnel syndrome [17]. The reported combined association of the COL5A1 rs12722 CC, COL11A1 rs3753841 CC, COL11A1 rs1676486 TT and COL11A2 rs1799907 AA genotypes in this study aligns with the reports by several researchers that showed that reduced knee hyperextension is associated with a decreased risk of ACL rupture [41] and that the COL5A1 rs12722 T allele was associated with increased knee hyperextension in females [11]. Future research should therefore evaluate these and other variants within the type XI collagen genes and the possible collective interactions with the COL5A1 variants and their effect on musculoskeletal tissue function and properties.
While COL5A1, COL11A1 and COL11A2 genotype-genotype interactions were significantly associated with passive and active genu recurvatum, these genetic interactions only predicted passive genu recurvatum measurements. Passive range of motion measurements are more likely to represent underlying biological differences in musculoskeletal soft tissue mechanical properties when compared to active measurements, which may be additionally influenced by muscle size and strength. A limitation of the in-silico musculoskeletal knee model used to calculate ligament length changes (in OpenSim) was that certain subjectspecific parameters could not be taken into account, such as bone geometry, joint space and joint capsule. The linear regression model presented in this study demonstrated the multifactorial nature of knee laxity as age, sex and body mass were all identified as predictors of genu recurvatum, but it also highlighted the contribution of specific genetic variants to knee laxity measurements. It is highly likely that the genetic contribution is polygenic. Since only four variants within three collagen genes were investigated in this study, future studies should investigate other genes involved in connective tissue biology. Moreover, the currently study had a relatively low sample size. Although associations were found, it is important that these associations are repeated in large cohorts. Since only a small number of participants included in this study tested positive for knee hyperextension, future research with a larger cohort may also investigate the association of these colla-gen genes within participants with symptomatic knee hyperextension and/or generalised joint hypermobility.
In conclusion, the findings of this study provide evidence supporting the role of variants within COL5A1, COL11A1 and COL11A2, together with physiological characteristics age, sex and body mass in collectively associating with measurements of laxity, specifically passive genu recurvatum.
Supplementary Materials: The following supporting information can be downloaded at https: //www.mdpi.com/article/10.3390/genes13122359/s1: Supplementary Table S1: The intraclass correlation coefficient (ICC), standard error of measurement (SEM) as well as the minimum detectable change at 90% confidence (MDC90) of genu recurvatum (passive and active) and anterior-posterior laxity (133 N anterior and posterior translation compliance index, active and maximum displacement) measurements in the non-dominant leg; Table S2: Descriptive data for the five trials of the reliability study for of genu recurvatum (passive and active) and anterior-posterior laxity (133 N anterior (Ant) and posterior (Post) translation (Trans), compliance index, active and maximum (Max) displacement) measurements in the non-dominant leg; Table S3: The COL5A1 rs12722 (T/C) genotype effects on the general characteristics, Beighton score and sit and reach measurements of participants with a history of an uninjured non-dominant leg; Table S4: The COL11A1 rs3753841 (T/C), rs1676486 (C/T) and COL11A2 rs1799907 (A/T) genotype effects on the general characteristics, Beighton score and sit and reach measurements of participants with a history of an uninjured non-dominant leg; Table S5: The COL5A1 rs12722 (T/C) genotype effects on the general characteristics, Beighton score and sit and reach measurements for the subset of participants with a history of an uninjured nondominant leg measured on the Robotic Knee Testing (RKT) device; Table S6: The COL11A1 rs3753841 (T/C) and COL11A2 rs1799907 (A/T) genotype effects on the general characteristics, Beighton score and sit and reach measurements for the subset of participants with a history of an uninjured nondominant leg measured on the Robotic Knee Testing (RKT) device; The COL5A1 rs12722 (T/C) genotype effects on the (i) passive and active genu recurvatum measurements, (ii) anterior (Ant) and posterior (Post) tibial translation, active and maximum (Max) displacement as well as compliance index measured using the KT-1000 arthrometer, and (iii) internal and external rotation, as well as slack measured using the Robotic Knee Testing (RKT) device of participants with a history of an uninjured non-dominant leg; Table S8: The COL11A1 rs3753841 (T/C), rs1676486 (C/T) and COL11A2 rs1799907 (A/T) genotype effects on the (i) passive and active genu recurvatum measurements, (ii) anterior (Ant) and posterior (Post) tibial translation, active and maximum (Max) displacement as well as compliance index measured using the KT-1000 arthrometer, and (iii) internal and external rotation, as well as slack measured using the Robotic Knee Testing (RKT) device of participants with a history of an uninjured non-dominant leg; Table S9: The COL5A1 rs12722 (T/C) genotype effects on the general characteristics, Beighton score and sit and reach measurements of participants with a history of an uninjured non-dominant leg, as well as those with a history of non-dominant lower limb injury and/or treatment; Table S10: The COL5A1 rs12722 (T/C) genotype effects on the (i) passive and active genu recurvatum measurements, and (ii) anterior (Ant) and posterior (Post) tibial translation, active and maximum (Max) displacement as well as compliance index measured using the KT-1000 arthrometer of participants with a history of an uninjured non-dominant leg, as well as those with a history of non-dominant lower limb injury and/or treatment; Table S11: The COL11A1 rs3753841 (T/C), rs1676486 (C/T) and COL11A2 rs1799907 (A/T) genotype effects on the general characteristics, Beighton score and sit and reach measurements of participants with a history of an uninjured non-dominant leg, as well as those with a history of non-dominant lower limb injury and/or treatment; Table S12: The COL11A1 rs3753841 (T/C), rs1676486 (C/T) and COL11A2 rs1799907 (A/T) genotype effects on the (i) passive and active genu recurvatum measurements, and (ii) anterior (Ant) and posterior (Post) tibial translation, active and maximum (Max) displacement as well as compliance index measured using the KT-1000 arthrometer of participants with a history of an uninjured non-dominant leg, as well as those with a history of non-dominant lower limb injury and/or treatment; Table S13: The COL5A1 rs12722 (T/C), COL11A1 rs3753841 (T/C), COL11A1 rs1676486 (T/C) and COL11A2 rs1799907 (A/T) genotype score effects on the general participant characteristics, Beighton score and sit and reach measurements; Table S14: The COL5A1 rs12722 (T/C), COL11A1 rs3753841 (T/C), COL11A1 rs1676486 (T/C) and COL11A2 rs1799907 (A/T) genotype score effects on the general participant characteristics, Beighton score and sit and reach measurements for the subset group of participants measured on the Robotic Knee Testing (RKT) device; Table S15: The COL5A1 rs12722 (T/C), COL11A1 rs3753841 (T/C), COL11A1 rs1676486 (T/C) and COL11A2 rs1799907 (A/T) genotype score effects on the (i) anterior (Ant) and posterior (Post) tibial translation, active and maximum (Max) displacement as well as compliance index measured using the KT-1000 arthrometer, and (ii) internal and external rotation, as well as slack measured using the Robotic Knee Testing (RKT) device of the participants' non-dominant leg; Table S16: The COL5A1 rs12722 (T/C), COL11A1 rs3753841 (T/C), COL11A1 rs1676486 (T/C) and COL11A2 rs1799907 (A/T) genotype score effects on the general characteristics, Beighton score and sit and reach measurements of participants with a history of an uninjured non-dominant leg, as well as those with a history of non-dominant lower limb injury and/or treatment; Table S17: The COL5A1 rs12722 (T/C), COL11A1 rs3753841 (T/C), COL11A1 rs1676486 (T/C) and COL11A2 rs1799907 (A/T) genotype score effects on the (i) passive and active genu recurvatum measurements, and (ii) anterior (Ant) and posterior (Post) tibial translation, active and maximum (Max) displacement as well as compliance index measured using the KT-1000 arthrometer of participants with a history of an uninjured non-dominant leg, as well as those with a history of non-dominant lower limb injury and/or treatment; Table S18: Summary of multiple linear regression model for active genu recurvatum of participants with a history of an uninjured non-dominant leg; Table S19: Summary of multiple linear regression model for passive genu recurvatum of participants with a history of an uninjured non-dominant leg. as well as those with a history of non-dominant lower limb injury and/or treatment; Table S20